JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB265206

Human ZCCHC17 (pNO40) knockout HeLa cell line

Be the first to review this product! Submit a review

|

(0 Publication)

ZCCHC17 KO cell line available to order. KO validated. Free of charge wild type control available. Knockout achieved by using CRISPR/Cas9, Homozygous: 8 bp deletion in exon 3. To order both knockout and wild-type control cells: select '2 x 1000000 Cells/vial'. To order only knockout cells: select '1000000 Cells/vial'.
1 Images
Sanger Sequencing - Human ZCCHC17 (pNO40) knockout HeLa cell line (AB265206)
  • Sanger seq

Unknown

Sanger Sequencing - Human ZCCHC17 (pNO40) knockout HeLa cell line (AB265206)

Homozygous : 8 bp deletion in exon 3.

Key facts

Cell type

HeLa

Species or organism

Human

Tissue

Cervix

Form

Liquid

form

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, Homozygous: 8 bp deletion in exon 3

Disease

Adenocarcinoma

Product details

We will provide viable cells that proliferate on revival.

This product is subject to limited use licenses from The Broad Institute and ERS Genomics Limited, and is developed with patented technology. For full details of the limited use licenses and relevant patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "2x1000000Cellsvial": { "sellingSize": "2 x 1000000 Cells/vial", "publicAssetCode":"ab265206-2x1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab255928 Human wild-type HeLa cell line", "number":"AB265206-CMP02" }, { "size":"1 x 1000000 Cells/vial", "name":"ab265206 Human ZCCHC17 (pNO40) knockout HeLa cell line", "number":"AB265206-CMP01" } ] }, "2x1000000Cellsvial": { "sellingSize": "2 x 1000000 Cells/vial", "publicAssetCode":"ab265206-2x1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab265206 Human ZCCHC17 (pNO40) knockout HeLa cell line", "number":"AB265206-CMP01" }, { "size":"1 x 1000000 Cells/vial", "name":"ab255928 Human wild-type HeLa cell line", "number":"AB265206-CMP02" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab265206-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab265206 Human ZCCHC17 (pNO40) knockout HeLa cell line", "number":"AB265206-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab265206-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab265206 Human ZCCHC17 (pNO40) knockout HeLa cell line", "number":"AB265206-CMP01", "productcode":"" } ] } } }

Properties and storage information

Gene name
ZCCHC17
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Zygosity
Homozygous
Shipped at conditions
Dry Ice
Appropriate short-term storage conditions
-196°C
Appropriate long-term storage conditions
-196°C

Handling procedures

Initial handling guidelines

Upon arrival, the vial should be stored in liquid nitrogen vapor phase and not at -80°C. Storage at -80°C may result in loss of viability.

1. Thaw the vial in 37°C water bath for approximately 1-2 minutes.
2. Transfer the cell suspension (0.8 mL) to a 15 mL/50 mL conical sterile polypropylene centrifuge tube containing 8.4 mL pre-warmed culture medium, wash vial with an additional 0.8 mL culture medium (total volume 10 mL) to collect remaining cells, and centrifuge at 201 x g (rcf) for 5 minutes at room temperature. 10 mL represents minimum recommended dilution. 20 mL represents maximum recommended dilution.
3. Resuspend the cell pellet in 5 mL pre-warmed culture medium and count using a haemocytometer or alternative cell counting method seed all remaining cells into a T25.
4. Incubate the culture at 37°C incubator with 5% CO2. Check the culture one day after revival and continue to check until 80% confluent. Media change can be given if needed.
5. Once confluent passage into an appropriate flask at a density of 2x104 cells/cm2. Seeding density is given as a guide only and should be scaled to align with individual lab schedules. Cultures should be monitored daily.

Subculture guidelines
  • All seeding densities should be based on cell counts gained by established methods.
  • A guide seeding density of 2x104 cells/cm2 is recommended.
  • Cells should be passaged when they have achieved 80-90% confluence.
Culture medium

DMEM (High Glucose) + 10% FBS

Cryopreservation medium

Cell Freezing Medium-DMSO Serum free media, contains 8.7% DMSO in MEM supplemented with methyl cellulose.

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

PNO40 also known as RPLP0 is a ribosomal protein that plays a mechanical role in the ribonucleoprotein complex responsible for peptide synthesis. It has a molecular mass of about 34 kDa and is ubiquitously expressed across various human tissues especially in the cytoplasm and nucleolus. pNO40 functions as a structural component of the ribosome participating in the assembly and stability of the ribosomal large subunit. The protein is essential for the proper formation of ribosomal RNA and optimal ribosome performance during translation.
Biological function summary

PNO40 engages significantly in ribosomal biogenesis and protein synthesis where it anchors the essential phosphoprotein complex of the ribosome. Its presence ensures that translation occurs effectively influencing cellular protein production. This protein is not part of a complex by itself but often interacts with acidic ribosomal phosphoproteins including RPLP1 and RPLP2 which are important for ribosomal assembly and function. The activity of pNO40 ensures the ribosome's structural integrity critical for maintaining cellular homeostasis.

Pathways

When considering translational machinery pNO40 actively participates in the translation pathway ensuring efficient protein synthesis. It associates with the ribosome-related pathway where it interacts with proteins like EF-G (Elongation Factor G) that catalyze the translocation of the ribosome along mRNA. These interactions are key to understanding how protein synthesis influences cellular response to environmental changes. The functionality of pNO40 within these pathways reflects its foundational role in maintaining cellular functions.

The expression and function of pNO40 have implications for certain types of cancer and anemia. In cancer altered levels of pNO40 can lead to dysregulated protein synthesis contributing to rapid cellular proliferation. This protein interacts with dysregulated pathways that also involve tumor suppressor proteins like p53. In anemia impairment of pNO40 can affect ribosome assembly reducing erythropoiesis. Understanding these interactions is important for potential therapeutic strategies targeting ribosomal biogenesis.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com